Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Prevnar 20 manufacturer?Activase alteplase price?Pneumovax 23 discontinued 2025 merck?Vyndamax 61 mg price?Amiodarone injection price?
See the DrugPatentWatch profile for Prevnar
Prevnar 20 (pneumococcal 20-valent conjugate vaccine) was approved by the FDA in 2021 and began commercial rollout in 2022 for routine use in the appropriate adult and pediatric populations, depending on the indication and schedule.
FDA approval came in 2021, which is the key date most launch timelines reference before products start shipping and being used more widely in clinics and pharmacies.
People sometimes mean different milestones: - FDA approval date (regulatory launch): when the product was authorized. - US commercial availability (market launch): when it became broadly available for clinicians/pharmacies after approval. - Guideline adoption (clinical launch): when professional recommendations and immunization schedules started including it for the relevant age groups. If you share whether you mean FDA approval, first US availability, or first inclusion in guidelines, I can pinpoint the exact date format you want.
Other Questions About Prevnar :